First DNA sequence transfer POC test debuts in healthcare industry

Date: 2018-04-16   Author: Saipriya Iyer  Category: #industry

First DNA sequence transfer POC test debuts in healthcare industry

The development team of DNAtix, a genetics blockchain firm, has reportedly declared that it has successfully conducted the first POC (proof of concept) test to transfer DNA sequences on the blockchain. The company that integrates blockchain and digitized genetics, is at the forefront of the global race in which healthcare industry firms are attempting to justify the shift from reactive treatment to ailment prevention & predictive care.

Co-founded in 2008 by Dr. Tal Sines and Ofer A. Lidsky, DNAtix is already reputed for having marketed a genetic test for the early identification of Androgenic Alopecia. In 2015, the firm developed a platform to help users upload and test their digital DNA sequences, which had been considered quite a commendable accomplishment in digital genome market back then.

As on early 2018, DNAtix has emerged successful in uploading an entire nucleotide sequence of a bacteriophage to the blockchain. The team has presently developed DNA compression algorithms that enable a reduction of 75% in DNA sequence size by means of the Python script. Further on, the development team intends to target an astonishing 99% reduction.

DNAtix’s efforts to reduce the DNA sequencing size apparently stems from the unfortunate fact that the currently available blockchain technologies are not efficient enough to support the extensive data size. And this situation for the record, has come up despite applying DNA compression methods & focusing on the differences between a reference sequence and the sequenced DNA. DNAtix’s latest initiative on these grounds would thus effectively impact the revenue graph of digital genome market, claim experts.

Incidentally, digital genome industry has already benefitted from DNAtix’s development of an innovative, one-stop-shop, direct-to-consumer platform designed to enable users perform a partial or complete DNA sequence analysis. In addition, they could choose digitized add-on tests from a wide service portfolio.

It has been speculated that DNAtix’s vision is to bring forth a cosmos of genetic possibilities that would aid R&D advancement, treatment development, and personalized medicine in healthcare industry.



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Abiogen Pharma takes over Altamedics in a deal worth $8 million

Author: Pankaj Singh

Italy-based pharmaceutical company Abiogen Pharma S.p.A. has reportedly completed the acquisition of Altamedics GmbH, a German pharmaceutical distribution company, which is slated to become the first foreign branch of ...


Healthcare Gamification Market Share, Size, Technology Advancement, Top Companies, Forecast 2027

Author: Rahul Varpe

DEC Research has published its most recent report with the title ‘Global Healthcare Gamification Market In-depth Research on Industry Size, Trends, Emerging Growth Factors to 2027’. The report basically contains an outline of the Healt...


Medical Gloves Market Share, Growth, Technology Advancements, and Forecast by 2030

Author: Rahul Varpe

DEC Research has published its most recent report with the title ‘Global Medical Gloves Market In-depth Research on Industry Size, Trends, Emerging Growth Factors to 2030’. The report basically contains an outline of the Medical Gloves...